Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Presence of few PD-1-expressing tumor-infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non-small cell lung cancer: An exploratory case series.
Ogawara D, Soda H, Tomono H, Iwasaki K, Hara T, Jinnai S, Funayama T, Okuno D, Taniguchi H, Yoshida M, Harada T, Umemura A, Fukuda Y, Yamaguchi H, Mukae H. Ogawara D, et al. Among authors: yoshida m. Thorac Cancer. 2018 Oct;9(10):1305-1311. doi: 10.1111/1759-7714.12844. Epub 2018 Aug 20. Thorac Cancer. 2018. PMID: 30126069 Free PMC article.
Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study.
Soda H, Ogawara D, Fukuda Y, Tomono H, Okuno D, Koga S, Taniguchi H, Yoshida M, Harada T, Umemura A, Yamaguchi H, Mukae H. Soda H, et al. Among authors: yoshida m. Thorac Cancer. 2019 Feb;10(2):341-346. doi: 10.1111/1759-7714.12952. Epub 2018 Dec 23. Thorac Cancer. 2019. PMID: 30582295 Free PMC article. Clinical Trial.
The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.
Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H. Miyazaki T, et al. Among authors: yoshida m. J Infect Chemother. 2019 Nov;25(11):886-893. doi: 10.1016/j.jiac.2019.04.019. Epub 2019 May 18. J Infect Chemother. 2019. PMID: 31113725 Free article. Clinical Trial.
An adult case of invasive pneumococcal disease due to serotype 12F-specific polysaccharide antibody failure following a 23-valent polysaccharide vaccination.
Tanaka Y, Yamamoto K, Fukuda Y, Umemura A, Yoshida M, Ideguchi S, Ashizawa N, Hirayama T, Tashiro M, Takazono T, Imamura Y, Miyazaki T, Izumikawa K, Yanagihara K, Chang B, Mukae H. Tanaka Y, et al. Among authors: yoshida m. Emerg Microbes Infect. 2020 Dec;9(1):2266-2268. doi: 10.1080/22221751.2020.1830716. Emerg Microbes Infect. 2020. PMID: 32990189 Free PMC article.
11,146 results
You have reached the last available page of results. Please see the User Guide for more information.